Cognition and Cognitive Training in Patients with Neurodegenerative Diseases

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurodegenerative Diseases".

Deadline for manuscript submissions: 15 August 2024 | Viewed by 605

Special Issue Editors


E-Mail Website
Guest Editor
Psychology Department, Faculty of Medicine and Psychology, Sapienza University of Rome, 00185 Rome, Italy
Interests: attention and awareness; decision making; EEG; neuropsychology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Neurodegenerative diseases such as Alzheimer's disease, Frontotemporal Dementia, Parkinson's disease and Multiple Sclerosis are a health priority throughout the world with huge medical, psychological and economic repercussions. Their prevalence and incidence have increased with age over recent decades, and they are expected to continue to grow in the near future.

As no effective treatments for cognitive symptoms are currently available, various studies have started to investigate the potential contribution of cognitive training (CT) in contrasting patients’ cognitive decay. However, to date the evidence supporting CT efficacy and effectiveness is weak and definitely needs to be fostered.

In this Special Issue, we are interested in studies focused on the application of CT to pathological cognitive ageing. We aim to attract empirical articles investigating the impact of paper-and-pencil and/or more technologically advanced training (i.e., computerized CT, virtual reality training, training based on neuromodulation tools, and so on) on main cognitive domains (i.e., memory, language, temporal and spatial orientation, attention, concentration, and executive functions) in patients affected by neurodegenerative conditions. Studies recruiting large samples of participants and/or adopting a longitudinal perspective are strongly encouraged. Review articles on the current state of the art in this field are also welcome.

Potential topics include (but are not limited to) the following:

  • Computerized cognitive stimulation studies in neurodegenerative diseases;
  • Studies using virtual reality technologies for cognitive stimulation purposes of neurodegenerative patients;
  • Neuroimaging, electrophysiology, and optical imaging studies of cognitive stimulation in dementias, other neurodegenerative conditions;
  • Empirical studies using novel technologies to assist cognitively impaired patients;
  • Long-term studies on the differences in quality of different cognitive stimulation techniques for patients with neurodegenerative disorders.

Dr. Marco Cavallo
Dr. Stefano Lasaponara
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cognitive training
  • neuroimaging
  • neurodegenerative diseases
  • neuromodulation
  • virtual reality

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 461 KiB  
Article
“Build Your Village”—Conducting the Village Test on Cognitively Impaired Patients: A First Journey into Alzheimerland
by Michelangelo Stanzani-Maserati, Maddalena De Matteis, Luca Bosco, Flavia Baccari, Corrado Zenesini, Micaela Mitolo, Chiara La Morgia, Roberto Gallassi and Sabina Capellari
Brain Sci. 2024, 14(6), 523; https://doi.org/10.3390/brainsci14060523 - 21 May 2024
Viewed by 316
Abstract
Background: This work aimed to study the Village Test (VT) in a group of patients with Alzheimer’s disease (AD) and compare the results with those of a group of patients with mild cognitive impairment (MCI) and controls. Methods: A total of 50 patients [...] Read more.
Background: This work aimed to study the Village Test (VT) in a group of patients with Alzheimer’s disease (AD) and compare the results with those of a group of patients with mild cognitive impairment (MCI) and controls. Methods: A total of 50 patients with AD, 28 patients with MCI, and 38 controls were evaluated. All participants underwent the VT and an extensive neuropsychological evaluation. Results: The mean ages of the participants were 74.4 years for those with AD, 74 for those with MCI, and 70.2 for the controls. The AD group built smaller and essential villages with a scarce use of pieces, a poor use of dynamic pieces, and scarce use of human figures. All constructions were often concentrated in the center of the table. Conclusions: The villages built by the AD group represent a cognitive and affective coarctation and indicate a sense of existential disorientation and isolation. The VT is a useful aid for getting in touch with the inner emotional and existential states of patients with AD, and it could represent a complementary screening tool for orienting cognitive impairment diagnoses. Full article
Back to TopTop